Raxar Lawsuit

Raxar, manufactured by Glaxo Smith Kline, was intended to treat a variety of infections.

Raxar was linked to potentially fatal side effects, including deadly arrhythmia (heart-rhythm disturbances), and was recalled in October 1997.

The manufacturer neglected to list the possibility of heart-rhythm disturbances on the drug label. Raxar is linked to 13 reported deaths.